Glycoaminoglycan (GAG) deficiency in protective barrier as an underlying, primary cause of ulcerative colitis, Crohn's disease interstitial cystitis and possibly Reiter's syndrome

Medical Hypotheses

Volumn 52, Issue 4, 1999, Pages 297-301

  Russell, A L ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; PENTOSAN POLYSULFATE;

CROHN DISEASE; EXTRAVASATION; FIBROSIS; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERSTITIAL CYSTITIS; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REITER SYNDROME; REVIEW; ULCERATIVE COLITIS;

EID: 0033052234     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1997.0652     Document Type: Article

References (31)

1. Cuvelier C., Mielants H., Quatacker J., De Vos M., Veys E. M., Roels H. Spondylarthropathy and gut inflammation: immunopathogenetic mechanisms. Int J Tiss Reac. XIV:1992;203-209.
2. Vidal y Plana R. R., Bizzarri D., Rovati A. L. Articular cartilage pharmacology. I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Commun. 10:1978;557-569.
3. Chatterjee S. S., Stefanovich V. Effect of anti-inflammatory agents on L-glutamine-D-fructose-6-phosphate transaminase. Arzneim-Forsh Drug Res. 26:1976;500-505.
4. Sunergren K. P., Fairman R. P., deBlois G. G., Glauser F. L. Effects of protamine, heparanase and hyaluronidase on endothelial permeability and surface change. J Appl Physiol. 63:1987;1987-1992.
5. Murch S. H., MacDonald T., Walker-Smith J., Levin M. Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet. 341:1993.
6. Sheahan D. G., Jervis H. R. Comparative histochemistry of gastrointestinal mucosubstances. Am J Anar. 146:1976;103-132.
7. Filipe M. I., Dawson I. The diagnostic value of mucosubstances in rectal biopsies from patients with ulcerative colitis and Crohn's Disease. Gut. 11:1970;229-234.
8. Goodman J., Kent P. W., Truelove C. Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Gut. 18:1977;219-228.
9. Burton, A. L. Freeman, H. Method and composition for treatment of lower gastrointestinal tract disorders, 1992.
10. McCarty M. F. The neglect of glucosamine as a treatment for osteoarthritis - a personal perspective. Med Hypotheses. 42:1994;323-327.
11. Russell, A. L. Glucosamine may be the catalyst for a shift in paradigm, Med Hypotheses.
12. Day C. E., Powell J. R., Levy R. S. Sulphated polysaccharide inhibition of aortic uptake of low density lipoproteins. Artery. 1:1974;127-137.
13. Morrison L. M., Varma R. Glycosaminoglycans and coronary heart disease. Glycosaminoglycans and Proteoglycans in Physiological and Pathological Processes of Body Systems. 1982;Karger, Basel. p. 214-230.
14. Herbert J. M., Nuti D., Paul R., Maffrand J. P. In vitro and ex vivo regulation of vascular smooth muscle cell growth and phenotypic modulation by sulphated polysaccharides. Artery. 16:1988;1-14.
15. Wilson S. K., Solez K., Boitnott J. K., Heptinstall R. H . The effects of heparin treatment of hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats. Am J Pathol. 102:1981;62-72.
16. Susic D., Mandal A. K., Kentera D. Heparin lowers the blood pressure in hypertensive rats. Hypertension. 4:1982;681-685.
17. Vasdev S., Prabhakaran V., Sampson C. A. Heparin lowers blood pressure and vascular calcium uptake in hypertensive rats. Scand J Clin Lab Invest. 51:1991;321-327.
18. Nitze, M. Lehrbuch der Cystoskopie: ihre Techik und Klinische Bedeuntung, J. E. Bergman, Berlin, 1908, 204, 210.
19. Parsons C. L., Parsons J. K. Interstitial cystitis. Raz S. Female Urology. 1996;WB Saunders, Philadelphla.
20. Ratcliff T. L., Klutke C. G., McDougall E. M. The etiology of interstitial cystitis. Urol Clin North Am. 21:1994;21-30.
21. Parsons C. L., Stein P. C., Bidair M., Lebow D. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodynamics. 13:1994;551-520.
22. Parsons C. L. The therapeutic role of sulphated polysaccharides in the urinary bladder. Urol Clin North Am. 21:1994;93-99.
23. Parsons C. L. Managing interstitial cystitis. Contemp Urol. 1990;1-4.
24. Sant G. R., LaRock D. R. Standard intravesical therapies for interstitial cystitis. Urol Clin North Am. 21:1994;73-82.
25. Morales A., Emerson L., Nickel J. C., Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 156:1996;45-48.
26. Grigsby P. W., Pilepich M. V., Parsons C. L. Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation/induced proctitis. Am J Clin Oncol. 13:1990;28-31.
27. Parsons, C. L. Personal communication, 1997.
28. Wedren H. Effects of sodium pentosan polysulphate on symptoms related to chronic non-bacterial prostatitis. A double blind randomized study. Scand J Urol Nephrol. 21:1987;81-88.
29. Hahn E., Timple R., Miller E. J. The production of specific antibodies to native collagens with the chain compositions, [al(I)][al(II)] and [al(I)a2]. J Immunol. 13:1974;421.
30. Nowack H., Hahn E., Timple R. Specificity of the antibody response in inbred mice to bovine type I and type Il collagen. Immunology. 29:1975;621.
31. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen: an experimental model of arthritis. J Exper Med. 146:1977;857.